Hygieia Group Limited (1650) AI Stock Analysis

• Market Cap: HK$184.00M
• Dividend Yield: 165.91%
• Average Volume (3M): 1.29M
• Price to Earnings (P/E): 41.8
• Beta (1Y): -0.40
• Revenue Growth: 12.50%
• EPS Growth: 69.23%
• Country: HK
• Employees: 2,690
• Sector: Industrials
• Sector Strength: 89
• Industry: Consulting Services
• EPS (TTM): >-0.01
• Shares Outstanding: 2,000,000,000
• 10 Day Avg. Volume: 1,568,000
• 30 Day Avg. Volume: 1,293,066
• PEG Ratio: -0.60
• Price to Book (P/B): 0.93
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -8.61
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: HK$0.00 ▼(-100.00%Downside)

Hygieia Group Limited's stock score is primarily supported by its solid financial foundation and strong equity position, which provide stability. However, the stock's high P/E ratio and overbought technical indicators suggest caution. The exceptionally high dividend yield is a significant positive factor, potentially attracting income-focused investors despite valuation concerns. The lack of earnings call data and notable corporate events limits further insights.

Hygieia Group Limited Business Overview & Revenue Model

Company Description

Hygieia Group Limited (1650) is a company focused on providing innovative healthcare solutions and services, primarily in the healthcare technology sector. The company specializes in developing and delivering advanced medical devices, software applications, and data analytics services aimed at improving patient outcomes and optimizing healthcare delivery. Hygieia Group Limited emphasizes its commitment to enhancing the quality of care through its core offerings, which include telehealth platforms, health monitoring systems, and integrated care solutions.

How the Company Makes Money

Hygieia Group Limited generates revenue through a multifaceted business model that includes the sale of medical devices, subscription services for software applications, and consulting services in healthcare analytics. Key revenue streams consist of direct sales of their proprietary healthcare products and licensing agreements for their software solutions. Additionally, the company benefits from partnerships with healthcare institutions and technology firms that enhance its market reach and product offerings. The increasing demand for telehealth solutions and data-driven healthcare services also contributes significantly to its earnings, given the growing emphasis on patient-centered care and the digital transformation of the healthcare industry.

Hygieia Group Limited Financial Statement Overview

Summary

Hygieia Group Limited shows moderate financial health with stable revenue growth but challenges in profitability and cash flow. The strong equity position provides stability, but there's a need for better operational efficiency and cash flow management.

Income Statement

The company demonstrates a moderate gross profit margin and a low net profit margin, indicating some pressure on profitability. Revenue has shown growth from the previous year, but the net income remains low compared to revenue. EBIT and EBITDA margins suggest room for operational efficiency improvements.

Balance Sheet

The balance sheet reveals a strong equity position and a manageable debt-to-equity ratio, indicating financial stability. The equity ratio is healthy, reflecting a strong asset base funded by equity. However, the return on equity is relatively low, suggesting less effective use of shareholder funds.

Cash Flow

Cash flow performance is mixed, with zero operating and free cash flow in the latest year, indicating potential liquidity challenges. Prior years showed positive cash flow, but the recent decline poses a risk. The company needs to improve cash generation to support growth and operations.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	74.70M	66.54M	63.42M	71.61M	72.61M
Gross Profit	9.65M	8.99M	8.60M	14.45M	22.16M
EBITDA	516.00K	3.24M	1.48M	9.02M	12.38M
Net Income	756.00K	454.00K	-1.60M	5.14M	8.80M
Balance Sheet
Total Assets	40.99M	44.48M	46.87M	56.53M	50.16M
Cash, Cash Equivalents and Short-Term Investments	18.43M	22.58M	27.52M	31.02M	22.63M
Total Debt	3.90M	6.04M	7.52M	9.47M	7.45M
Total Liabilities	13.06M	14.38M	15.27M	18.84M	17.57M
Stockholders Equity	27.82M	30.05M	31.60M	37.70M	32.55M
Cash Flow
Free Cash Flow	1.50M	146.00K	4.14M	8.79M	6.58M
Operating Cash Flow	2.17M	1.04M	5.08M	9.87M	7.22M
Investing Cash Flow	2.60M	-815.00K	-10.41M	1.72M	-3.11M
Financing Cash Flow	-6.64M	-5.52M	-8.19M	-675.00K	3.43M

Hygieia Group Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.09
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1650, the sentiment is Positive. The current price of 0.09 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.08, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 97.93 is Negative, neither overbought nor oversold. The STOCH value of 85.71 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1650.

Hygieia Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8501	59 Neutral	HK$87.10M	―	-2.95%	―	-47.50%	-335.68%
1650	58 Neutral	HK$184.00M	41.82	2.60%	165.91%	12.50%	69.23%
Sector *	58 Neutral	HK$15.00B	4.65	-2.78%	5.84%	3.80%	-54.57%
1376	52 Neutral	HK$116.00M	―	5.82%	―	-48.30%	-395.18%
3893	46 Neutral	HK$29.11M	―		―	151.24%	46.43%
1867	43 Neutral	HK$224.10M	―	-41.79%	―	-49.08%	-363.83%
8455	39 Underperform	HK$59.52M	―	-617.73%	―	-4.49%	51.39%

Hygieia Group Limited Corporate Events

Hygieia Group Limited Appoints New Independent Non-Executive Director

Hygieia Group Limited has announced the appointment of Mr. Leung as an independent non-executive director. Mr. Leung has confirmed his independence according to the Listing Rules, with no financial or other interests in the company, ensuring no factors affect his independence at the time of his appointment.

Hygieia Group Limited Updates Final Dividend Payment Details

Hygieia Group Limited announced an update regarding its cash dividend for the financial year ending 31 December 2024. The final ordinary dividend declared is SGD 0.002 per share, equivalent to HKD 0.012108 per share, with the payment date set for 06 June 2025. This update includes details on the exchange rate and currency in which the dividend will be paid, reflecting the company’s commitment to maintaining shareholder value.

Hygieia Group Limited’s AGM Resolutions Unanimously Approved

Hygieia Group Limited announced that all proposed resolutions at its annual general meeting held on May 15, 2025, were passed unanimously. These resolutions included the approval of financial statements, declaration of a final dividend, re-election of directors, and granting of mandates to issue and buy back shares. The unanimous approval reflects strong shareholder support and may positively impact the company’s governance and market operations.